This podcast is supported by Sanofi Regeneron.
The third podcast in this three-part series discusses access to treatment disparities for nasal polyposis in minority and underserved populations.
Today’s speakers have the following disclosures:
- Gerald Lee, MD: Nothing to disclose
- Maha Mahdavinia, MD, PhD: Consulting, Fee: Optinose
- Anjeni Keswani, MD: Nothing to disclose
Disparities in Chronic Rhinosinusitis With Nasal Polyps Miniseries – Episode 3
ACAAI presents this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to the procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that may be referenced.
